vs

Side-by-side financial comparison of Blue Hat Interactive Entertainment Technology (BHAT) and UTAH MEDICAL PRODUCTS INC (UTMD). Click either name above to swap in a different company.

Blue Hat Interactive Entertainment Technology is the larger business by last-quarter revenue ($13.1M vs $9.0M, roughly 1.4× UTAH MEDICAL PRODUCTS INC). UTAH MEDICAL PRODUCTS INC runs the higher net margin — 28.4% vs -9.9%, a 38.3% gap on every dollar of revenue.

Blue Hat Interactive Entertainment Technology develops and produces interactive entertainment products including AR games, smart interactive toys, and immersive leisure content. It primarily serves mainland China's consumer market, with expanding distribution across Southeast Asia, focusing on family and youth entertainment segments.

Varian Medical Systems is an American radiation oncology treatments and software maker based in Palo Alto, California. Their medical devices include linear accelerators (LINACs) and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies software for managing cancer clinics, radiotherapy centers, and medical oncology practices. Varian Medical Systems employs more than 7,100 people at manufacturing sites...

BHAT vs UTMD — Head-to-Head

Bigger by revenue
BHAT
BHAT
1.4× larger
BHAT
$13.1M
$9.0M
UTMD
Higher net margin
UTMD
UTMD
38.3% more per $
UTMD
28.4%
-9.9%
BHAT

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
BHAT
BHAT
UTMD
UTMD
Revenue
$13.1M
$9.0M
Net Profit
$-1.3M
$2.6M
Gross Margin
8.3%
58.2%
Operating Margin
-9.4%
27.0%
Net Margin
-9.9%
28.4%
Revenue YoY
-1.2%
Net Profit YoY
-11.6%
EPS (diluted)
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHAT
BHAT
UTMD
UTMD
Q4 25
$9.0M
Q3 25
$9.8M
Q2 25
$13.1M
$10.0M
Q1 25
$9.7M
Q4 24
$9.2M
Q3 24
$10.0M
Q2 24
$46.3M
$10.4M
Q1 24
$11.3M
Net Profit
BHAT
BHAT
UTMD
UTMD
Q4 25
$2.6M
Q3 25
$2.6M
Q2 25
$-1.3M
$3.0M
Q1 25
$3.0M
Q4 24
$2.9M
Q3 24
$3.6M
Q2 24
$-4.4M
$3.5M
Q1 24
$4.0M
Gross Margin
BHAT
BHAT
UTMD
UTMD
Q4 25
58.2%
Q3 25
57.1%
Q2 25
8.3%
56.2%
Q1 25
57.0%
Q4 24
58.1%
Q3 24
58.0%
Q2 24
0.2%
60.1%
Q1 24
59.7%
Operating Margin
BHAT
BHAT
UTMD
UTMD
Q4 25
27.0%
Q3 25
26.6%
Q2 25
-9.4%
32.1%
Q1 25
32.5%
Q4 24
32.0%
Q3 24
33.4%
Q2 24
-8.8%
33.1%
Q1 24
34.2%
Net Margin
BHAT
BHAT
UTMD
UTMD
Q4 25
28.4%
Q3 25
26.8%
Q2 25
-9.9%
30.6%
Q1 25
31.3%
Q4 24
31.7%
Q3 24
35.6%
Q2 24
-9.4%
33.2%
Q1 24
34.9%
EPS (diluted)
BHAT
BHAT
UTMD
UTMD
Q4 25
$0.80
Q3 25
$0.82
Q2 25
$0.94
Q1 25
$0.92
Q4 24
$0.86
Q3 24
$1.03
Q2 24
$0.98
Q1 24
$1.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHAT
BHAT
UTMD
UTMD
Cash + ST InvestmentsLiquidity on hand
$14.3K
$85.8M
Total DebtLower is stronger
$225.0K
Stockholders' EquityBook value
$32.1M
$119.3M
Total Assets
$75.2M
$122.5M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHAT
BHAT
UTMD
UTMD
Q4 25
$85.8M
Q3 25
$84.3M
Q2 25
$14.3K
$82.2M
Q1 25
$83.3M
Q4 24
$83.0M
Q3 24
$88.5M
Q2 24
$407.6K
$89.2M
Q1 24
$93.8M
Total Debt
BHAT
BHAT
UTMD
UTMD
Q4 25
$225.0K
Q3 25
Q2 25
Q1 25
$269.0K
Q4 24
$282.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BHAT
BHAT
UTMD
UTMD
Q4 25
$119.3M
Q3 25
$118.3M
Q2 25
$32.1M
$117.5M
Q1 25
$117.0M
Q4 24
$117.4M
Q3 24
$124.2M
Q2 24
$40.6M
$124.1M
Q1 24
$127.7M
Total Assets
BHAT
BHAT
UTMD
UTMD
Q4 25
$122.5M
Q3 25
$122.0M
Q2 25
$75.2M
$120.8M
Q1 25
$122.5M
Q4 24
$122.5M
Q3 24
$129.7M
Q2 24
$49.3M
$130.0M
Q1 24
$135.4M
Debt / Equity
BHAT
BHAT
UTMD
UTMD
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHAT
BHAT
UTMD
UTMD
Operating Cash FlowLast quarter
$2.6M
$3.5M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
37.2%
Capex IntensityCapex / Revenue
1.2%
Cash ConversionOCF / Net Profit
1.36×
TTM Free Cash FlowTrailing 4 quarters
$14.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHAT
BHAT
UTMD
UTMD
Q4 25
$3.5M
Q3 25
$3.9M
Q2 25
$2.6M
$2.9M
Q1 25
$4.5M
Q4 24
$2.9M
Q3 24
$3.9M
Q2 24
$2.8M
Q1 24
$5.3M
Free Cash Flow
BHAT
BHAT
UTMD
UTMD
Q4 25
$3.4M
Q3 25
$3.9M
Q2 25
$2.8M
Q1 25
$4.3M
Q4 24
$2.9M
Q3 24
$3.8M
Q2 24
$2.7M
Q1 24
$5.3M
FCF Margin
BHAT
BHAT
UTMD
UTMD
Q4 25
37.2%
Q3 25
39.2%
Q2 25
28.4%
Q1 25
44.1%
Q4 24
32.0%
Q3 24
37.7%
Q2 24
25.5%
Q1 24
46.3%
Capex Intensity
BHAT
BHAT
UTMD
UTMD
Q4 25
1.2%
Q3 25
0.3%
Q2 25
0.5%
Q1 25
1.9%
Q4 24
0.1%
Q3 24
0.9%
Q2 24
1.1%
Q1 24
0.2%
Cash Conversion
BHAT
BHAT
UTMD
UTMD
Q4 25
1.36×
Q3 25
1.47×
Q2 25
0.94×
Q1 25
1.47×
Q4 24
1.01×
Q3 24
1.08×
Q2 24
0.80×
Q1 24
1.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons